Tramadol Hydrochloride Tablet, Coated
Product Images NDC 65162-627

4 FDA label images from Amneal Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 65162-627). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)
Chemical structure of Tramadol Hydrochloride, showing its molecular arrangement with functional groups including a methoxyphenyl group, cyclohexanol ring, and a dimethylamino side chain.*
FDA Label Image

Figure 1 (Tramadol HCl Tablets Usp 2)

Figure 1 (Tramadol HCl Tablets Usp 2)
A pharmacokinetic curve depicting concentration (ng/mL) versus time (hours) for Tramadol Hydrochloride and its metabolite M1 after administration. The graph shows multiple and single dose profiles for both Tramadol and M1 over a 48-hour period, indicating concentration decay and duration in plasma.*
FDA Label Image

Fig 2 (Tramadol HCl Tablets Usp 3)

Fig 2 (Tramadol HCl Tablets Usp 3)
A line chart titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' displaying percent discontinuing on the y-axis and days in double-blind study on the x-axis. The chart compares two groups over 25 days: one with 10 days to 200 mg/day (solid red line) and one with 16 days to 200 mg/day (blue dashed line). Percent discontinuing increases more steeply in the 10-day group than in the 16-day group.*
FDA Label Image

20 (Tramadol HCl Tablets Usp 4)

20 (Tramadol HCl Tablets Usp 4)
Tramadol Hydrochloride Tablets, USP 50 mg coated tablets label from Amneal Pharmaceuticals LLC. The label shows NDC 65162-627-01, recommends pharmacy dispensing with medication guide, and states storage conditions at controlled room temperature. It includes manufacturer and distributor information from Amneal Pharmaceuticals of NY LLC and Amneal Pharmaceuticals LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.